Skip to main content

Year: 2025

Lantronix Founder Bernhard Bruscha Donates 3.0 million shares of Lantronix Common Stock to TL Stiftung (TL Foundation)

IRVINE, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in compute and connectivity IoT solutions powering Edge AI applications, today announced that its founder, Bernhard Bruscha, has donated 3.0 million shares of Lantronix common stock from his individual holdings to the TL Stiftung (TL Foundation), an independent charitable foundation based in Germany. Following the donation, Mr. Bruscha continues to hold more than 2.3 million shares in his individual holdings. “I am proud to dedicate a portion of my holdings to the TL Stiftung in support of its mission to promote scientific research, education and the well-being of underserved communities,” said Bruscha, who founded the TL Stiftung in 2000. “At the same time, I continue to hold more than 2.3 million shares in my personal capacity and...

Continue reading

Bombardier Advances Services Expansion as Construction of Landmark Abu Dhabi Facility Accelerates

Construction advancing at Al Bateen Executive Airport (AZI), with the facility on track to open in the second half of 2026(1) The new service centre will serve as a key hub for Bombardier business aircraft operations across the Middle East The 120,000 sq. ft. service facility will deliver world-class maintenance capabilities for Bombardier’s entire aircraft portfolio, including the soon–to enter-into-service Global 8000(2)Executives from Abu Dhabi Airports join Bombardier leadership at site of the company’s landmark Abu Dhabi service centre ABU DHABI, United Arab Emirates, Dec. 04, 2025 (GLOBE NEWSWIRE) — Bombardier today announced significant progress on its new state-of-the-art service centre at the Al Bateen Executive Airport (AZI). Construction has advanced, with the structural framework of the main building and hangar...

Continue reading

Hapbee Appoints Hasan Shahid to Board of Directors to Strengthen Capital Markets & Strategic Growth Capabilities

Seasoned technologist, investor, and capital markets leader joins Hapbee’s Board VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Hapbee Technologies, Inc. (TSXV: HAPB; OTCQB: HAPBF; FWB: HA1) (“Hapbee” or the “Company”) is pleased to announce the appointment of Hasan Shahid to its Board of Directors. Mr. Shahid brings more than 25 years of experience across technology, digital transformation, capital markets, and alternative investments, strengthening the Company’s strategic capabilities as it continues scaling its platform and partnerships. Hasan Shahid is the Founder and Chief Investment Officer of League Capital, a New York–based hedge fund specializing in technology, artificial intelligence, digital assets, and alternative investment strategies. Under his leadership, League Capital has delivered exceptional performance...

Continue reading

Columbus Circle Capital Corp I Shareholders Approve Business Combination with ProCap BTC

New York, New York, Dec. 03, 2025 (GLOBE NEWSWIRE) — Columbus Circle Capital Corp I (“BRR”) (Nasdaq: BRR) and ProCap BTC, LLC (“ProCap BTC”), a modern financial services firm leveraging bitcoin, today announced that BRR’s shareholders voted to approve the proposed business combination with ProCap BTC (“Business Combination”) at an extraordinary general meeting held today. The Business Combination is expected to close on or about Friday, December 5, 2025, subject to the satisfaction or waiver of all closing conditions. Following the closing of the transaction, the go‑forward public company will be named ProCap Financial, Inc. (“ProCap Financial”) and its common stock is expected to begin trading on the Nasdaq Global Market under the symbol “BRR” following the closing of the transaction. A Current...

Continue reading

Axogen Announces FDA Approval of Biologics License Application for AVANCE® (acellular nerve allograft–arwx)

ALACHUA, Fla. and TAMPA, Fla., Dec. 03, 2025 (GLOBE NEWSWIRE) — Axogen, Inc. (NASDAQ: AXGN), a global leader in developing and marketing innovative surgical technologies for the restoration of peripheral nerve function, today announced that the U.S. Food and Drug Administration (the “FDA”) has approved the Biologics License Application (“BLA”) for AVANCE® (acellular nerve allograft-arwx). Avance is an acellular nerve scaffold for the treatment of adult and pediatric patients aged 1 month or older with sensory, mixed, and motor peripheral nerve discontinuities. The indications for sensory nerve discontinuities >25mm and for mixed and motor nerve discontinuities were approved under FDA’s Accelerated Approval pathway based on the effect on static two-point discrimination in sensory nerve gaps ≤25mm, which provided empirical evidence...

Continue reading

NovaBridge Announces Presentation of Ragistomig Expanded Phase 1 Data at ESMO-IO

Ragistomig is a 4-1BB X PD-L1 bispecific antibody, designed to treat patients who are relapsed or refractory to checkpoint inhibitors, a multi-billion dollar drug class hampered by widespread resistance The Phase 1 ragistomig study achieved its objective, as the new Q6W extended dosing interval produced strong anti-tumor efficacy in PD-L1-non-responders, with an improved safety profile The interim results, including immunological data on CD8+ cell proliferation and memory T-cell activation, are expected to be presented in a poster session at ESMO-IO on December 10, 2025ROCKVILLE, Md., Dec. 03, 2025 (GLOBE NEWSWIRE) — NovaBridge Biosciences (Nasdaq: NBP) (NovaBridge or the Company) a global biotechnology platform company committed to accelerating access to innovative medicines, today announced that new data from the expanded...

Continue reading

Regentis Biomaterials Ltd. Announces Pricing of Initial Public Offering

Herzliya, Israel, Dec. 03, 2025 (GLOBE NEWSWIRE) — Regentis Biomaterials Ltd. (NYSE American: RGNT) (“Regentis”, or the “Company”), a regenerative medicine company dedicated to developing innovative tissue repair solutions that seek to restore the health and enhance the quality of life of patients, today announced the pricing of its initial public offering (the “Offering”) of 1,250,000 ordinary shares (“Ordinary Shares”) at an initial public offering price of $8.00 per Ordinary Share, for aggregate gross proceeds of $10,000,000 before deducting underwriting discounts and estimated offering expenses payable by the Company. In addition, the Company has granted the underwriters a 45-day option to purchase up to an additional 187,500 Ordinary Shares to cover over-allotments, if any. The Ordinary Shares are expected to begin trading...

Continue reading

FTI Consulting Appoints Jason Leow to Strategic Communications Segment in Singapore

SINGAPORE, Dec. 03, 2025 (GLOBE NEWSWIRE) — FTI Consulting, Inc. (NYSE: FCN) today announced the appointment of Jason Leow as a Senior Managing Director within the firm’s Strategic Communications segment. Mr. Leow, who is based in Singapore, brings more than 25 years of experience in financial communications, C-suite advisory and stakeholder engagement across Asia, Europe and the United States. In his role at FTI Consulting, he will work closely with the Asia Leadership Team and the firm’s global Senior Managing Director group to drive growth across Southeast Asia and strengthen alignment within the firm’s international Strategic Communications network. His appointment underscores the firm’s commitment to expanding its strategic communications capabilities in the region, particularly in areas such as M&A, ESG, shareholder...

Continue reading

Monument Announces First 16 Drill Hole Results Of Selinsing Mine Expansion Drilling Program

VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Monument Mining Limited (TSX-V: MMY and FSE: D7Q1)(“Monument” or the “Company”) is pleased to announce the first 16 drill hole results from its first BR/Felda mine expansion drilling program and update mine expansion drilling activities at the Selinsing Gold Mine including Selinsing and Buffalo Reef gold projects, located in Pahang State on the Central Gold Belt of Western Malaysia. Ms. Cathy Zhai, President and CEO of Monument Mining commented: “We are encouraged by the first 16 drill hole assay results from the exploration drill program within targeted potential mine expansion areas, including both outside of Buffalo Reef/Felda pit shells (“BR/Felda mine expansion drilling”) and Selinsing pit shells (“Selinsing mine expansion drilling”)...

Continue reading

Mustang Energy Corp. Stakes Two New Mineral Properties in Newfoundland: Onyx Uranium Project and Bridal Veil Copper–Silver Project

VANCOUVER, British Columbia, Dec. 03, 2025 (GLOBE NEWSWIRE) — Mustang Energy Corp. (CSE: MEC, OTC: MECPF, FRA: 92T) (the “Company” or “Mustang”) is pleased to announce that it has staked two new mineral exploration properties in Newfoundland and Labrador — the Onyx Uranium Project (the “Onyx Project”) in southern Newfoundland and the Bridal Veil Copper–Silver Project (the “Bridal Veil Project”) in central Newfoundland — consisting of a combined 446 claims totaling approximately 3,875 hectares. Together, these acquisitions mark Mustang’s first move into eastern Canada and represent a strategic expansion of its exploration portfolio beyond Saskatchewan’s Athabasca Basin. Strategic Expansion into Newfoundland As part of this expansion, Mustang has completed its extra-provincial registration and is now authorized to conduct business...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.